newwin
Luciann Nguyen
Settings
← Accounts
biotech

Claus Lindbjerg Andersen

59
Account opportunity
Not established
Relationship
1
Active signals
1
Trials as sponsor

Why this account matters

59/100
Opportunity
Commercial fit17/25
Clinical timing13/20
Biomarker need10/20
Relationship2/10
Signal strength9/10
Account value7/10
Urgency1/5

New unknown trial NCT06111105 posted by Claus Lindbjerg Andersen: "GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Colorectal Cancer". New trial on a unknown recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).

Why nowClinicalTrials.gov record updated 127 days ago.

ConfidenceHigh · 95%clinical development · translational medicine · clinical operations

NextMap clinical development and translational medicine stakeholders on the sponsor, confirm no colleague is mid-conversation, then draft evidence-based outreach.

Trials

TrialPhaseTesting language
NCT06111105
GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Colorectal Cancer
unknown
ctDNA